retatrutide clinical trials efficacy studies Retatrutide, an experimental drug currently in Phase 3 clinical trials, is nicknamed the Retatrutide Weekly Weight Loss Injection
Description
Roughly 40 million Americans carry FSA or HSA balances each year, yet many remain unaware that compounded GLP-1 medications qualify as eligible medical expenses

A Phase 2a trial published in Nature Medicine showed Retatrutide significantly reduced liver fat and improved insulin sensitivity in MASLD patients
Semaglutide carries an FDA warning about thyroid C-cell tumors occurring in rodents (with unknown risk in humans), and Semaglutide should not be used if you or your family have a history of certain thyroid cancers

Zhang L, Zhang L, Li L, Hlscher C
00967-0/asset/1cda1e69-507e-47d1-ad73-620bcd1cbb66/main.assets/gr2_lrg.jpg)